Viva Biotech Holdings (1873.HK)
HKD 0.89
(-2.2%)
HKD 0.89
(-2.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.15 Billion | 2.37 Billion | 2.1 Billion | 696.95 Million | 323.05 Million | 210.03 Million |
| Cost of Revenue | 1.41 Billion | 1.56 Billion | 1.45 Billion | 392.09 Million | 167.18 Million | 104.57 Million |
| Gross Profit | 738.43 Million | 815.67 Million | 650.98 Million | 304.86 Million | 155.87 Million | 105.45 Million |
| Operating Expenses | 545.74 Million | 1.11 Billion | 146.74 Million | 615.65 Million | 112.22 Million | 100 Thousand |
| Selling, General and Administrative Expenses | 417.78 Million | 410.49 Million | 321.69 Million | 123.25 Million | 54.78 Million | 29.61 Million |
| Research and Development Expenses | 127.96 Million | 135.83 Million | 92.38 Million | 66.04 Million | 44.95 Million | 25.25 Million |
| Other Expenses | - | -1.44 Million | 133.25 Million | -582.63 Million | -34.2 Million | - |
| Cost and Expenses | 1.96 Billion | 2.67 Billion | 1.59 Billion | 1 Billion | 279.41 Million | 104.67 Million |
| Operating Income | 192.68 Million | 265.98 Million | 236.9 Million | 112.53 Million | 54.32 Million | 50.59 Million |
| Interest Expense | 176.58 Million | 184.67 Million | 183.1 Million | 62.13 Million | 2.26 Million | - |
| Income Tax Expense | 43.83 Million | 45.05 Million | 47.14 Million | 22.66 Million | 15.05 Million | 15.31 Million |
| Earnings before Tax | -55.95 Million | -459.16 Million | 347.7 Million | -356.21 Million | 280.92 Million | 105.86 Million |
| Net Income | -116.11 Million | -528.47 Million | 287.54 Million | -386.88 Million | 265.87 Million | 90.55 Million |
| Earnings Per Share Basic | -0.14 | -0.28 | 0.15 | -0.25 | 0.19 | 0.08 |
| Earnings Per Share Diluted | -0.06 | -0.28 | 0.15 | -0.25 | 0.18 | 0.08 |
| Weighted Average Shares Outstanding | 811.04 Million | 1.88 Billion | 1.91 Billion | 1.54 Billion | 1.47 Billion | 1.13 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.02 Billion | 1.91 Billion | 1.97 Billion | 1.57 Billion | 1.48 Billion | 1.19 Billion |
| Gross Margin | 0.34 | 0.34 | 0.31 | 0.44 | 0.48 | 0.50 |
| EBIT Margin | 0.18 | 0.18 | 0.18 | 0.24 | 0.22 | 0.29 |
| Profit Margin | -0.05 | -0.22 | 0.14 | -0.56 | 0.82 | 0.43 |
| EBITDA | 391.01 Million | -89.03 Million | 369.93 Million | -223.89 Million | 70.78 Million | 60.14 Million |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.11 | 0.16 | 0.17 | 0.24 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 981.82 Million | 1.01 Billion | 2.15 Billion | 1.14 Billion | 2.37 Billion | 1.27 Billion |
| Cost of Revenue | 642.67 Million | 680.93 Million | 1.41 Billion | 736.21 Million | 1.56 Billion | 800.17 Million |
| Gross Profit | 339.14 Million | 332.46 Million | 738.43 Million | 405.96 Million | 815.67 Million | 470.7 Million |
| Operating Expenses | 217.59 Million | 265.21 Million | 482.3 Million | 294.57 Million | 1.11 Billion | 781.51 Million |
| Selling, General and Administrative Expenses | 174.76 Million | 213.94 Million | - | 203.83 Million | - | 212.08 Million |
| Research and Development Expenses | 42.82 Million | 51.26 Million | - | 76.7 Million | - | 94.91 Million |
| Other Expenses | - | - | 164.27 Million | - | -1.44 Million | - |
| Cost and Expenses | 860.27 Million | 946.14 Million | 1.89 Billion | 1.03 Billion | 2.67 Billion | 1.58 Billion |
| Operating Income | 121.55 Million | 67.25 Million | 192.68 Million | 124.87 Million | 265.98 Million | 165.19 Million |
| Interest Expense | - | - | 176.58 Million | - | 184.67 Million | - |
| Income Tax Expense | 41.27 Million | 20.74 Million | 43.83 Million | 23.09 Million | 45.05 Million | 23.3 Million |
| Earnings before Tax | 185.51 Million | -92.7 Million | -55.95 Million | 36.75 Million | -459.16 Million | -395.69 Million |
| Net Income | 116.8 Million | -117.12 Million | -116.11 Million | 1.01 Million | -528.47 Million | -437.27 Million |
| Earnings Per Share Basic | 0.05 | -0.05 | - | 0.00 | - | -0.23 |
| Earnings Per Share Diluted | 0.05 | -0.05 | - | 0.00 | - | -0.23 |
| Weighted Average Shares Outstanding | 2.33 Billion | 2.13 Billion | 1.94 Billion | 1.91 Billion | 1.88 Billion | 1.91 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.14 Billion | 2.14 Billion | 2.02 Billion | 1.91 Billion | 1.91 Billion | 1.91 Billion |
| Gross Margin | 0.35 | 0.33 | 0.34 | 0.36 | 0.34 | 0.37 |
| EBIT Margin | 0.22 | 0.16 | - | 0.20 | - | 0.20 |
| Profit Margin | 0.12 | -0.12 | -0.05 | 0.00 | -0.22 | -0.34 |
| EBITDA | 215.46 Million | 162.88 Million | - | 228.13 Million | - | 252.07 Million |
| Earnings Before Tax Margin | 0.12 | 0.07 | 0.09 | 0.11 | 0.11 | 0.13 |
1453
MV4
BNP
002554
EXTO
IZNN